Of the 30 patients who were given the drug, 29 showed marked improvement within two days

An Israeli hospital may have found the cure for COVID-19 in a potential game changer in the fight against the global pandemic, according to the Tel Aviv Sourasky Medical Center, also known as Ichilov Hospital.

The medicine's developer, Prof Nadir Arber from the hospital's Integrated Cancer Prevention Center, administered it to patients in moderate and serious condition, reporting an impressive success rate of 96 percent.

Prof Arber hailed the drug dubbed EXO-CD24 as "effective inexpensive."

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

'The medicine is administered through inhalation, once a day, in a procedure that takes only a few minutes, for five days," Prof Arber specified.

"It is based on exosomes that the body is releasing from the cell membrane and uses for intercellular communication. We enrich the exosomes with the 24CD protein, which is known to play an important role in regulating the immune system," according to Prof Arber's director of laboratory Dr. Shiran Shapira, who has been conducting research on CD24 protein for over two decades.

Of the 30 patients who were given the drug, 29 showed marked improvement within two days and were released from the hospital three to five days later. Read more at i24